Nano-H, ARGENT industrial partner, and its clinical developer NH Theraguix, selected as Laureate at “16th Tremplin Entreprises”
On June 20th 2016, NH Theraguix, a new startup dedicated to the clinical translation of AGuIX®, the nanoparticle developed by Nano-H and used in many ESRs’ research projects, was selected as one of 30 laureates among 380 most innovating enterprises in the final of the prestigious “16th Tremplin Entreprises” competition organized by French Senate and ESSEC Business School in Paris. More impressively, it was awarded “Prix coup de coeur”, Prize for favorite choices, given by French Association of Biotechnologies along with two other firms. AGuIX® surpassed many other competitors thanks to the originality and maturity of the technology and its great potential for being translated into clinical uses. Two supervisors of ESR Vu Long Tran, Prof. Olivier Tillement and Dr. François Lux, are senior members of the new startup.